|  |  |  |  | P-value |
---|---|---|---|---|---|
Covariate |  | Patients with data on falls in follow-up period available (n = 3681) | Non-fallers (n = 2912) | Fallers (n = 769) | Non- fallers vs. fallers |
Age | 70–74 | 815 (22.1) | 676 (23.2) | 139 (18.1) | 0.005 |
75–79 | 1007 (27.4) | 784 (26.9) | 223 (29.0) | ||
80–84 | 1038 (28.2) | 827 (28.4) | 211 (24.4) | ||
≥85 | 821 (22.3) | 625 (21.5) | 196 (25.5) | ||
Sex | Female | 2080 (56.5) | 1672 (57,4) | 408 (53.1) | 0.036 |
Male | 1601 (43.5) | 1240 (42, 5) | 361 (46.9) | ||
Diagnosis General | Solid tumor | 3352 (91.1) | 2665 (91.5) | 687 (89.3) | 0.065 |
Hematologic malignancy | 329 (8.9) | 247 (8.5) | 82 (10.7) | ||
Diagnosis Specific | New diagnosis | 2907 (79.0) | 2303 (79.1) | 604 (78.5) | 0.743 |
Relapse/Progression | 774 (21.0) | 609 (20.9) | 165 (21.5) | ||
CCIa | No comorbidities (0) | 989 (27.0) | 806 (27.8) | 183 (23.9) | 0.028 |
Comorbidities (≥1) | 2671 (73.0) | 2089 (72.2) | 582 (76.1) | ||
Polypharmacya | No polypharmacy (0–4) | 1355 (37.3) | 1124 (39.1) | 231 (30.3) | < 0.0001 |
Polypharmacy (≥5) | 2279 (62.7) | 1748 (60.9) | 531 (69.7) | ||
ECOG-PS | Score 0–1 | 2098 (57.0) | 1732 (59.5) | 366 (47.6) | < 0.0001 |
Score 2–4 | 1583 (43.0) | 1180 (40.5) | 403 (52.4) | ||
Living situation | Not living alone | 2374 (64.5) | 1889 (64.9) | 485 (63.1) | 0.354 |
Living alone | 1307 (35.5) | 1023 (35.1) | 284 (36.9) | ||
Professional home carea | No | 1696 (46.1) | 1382 (47.5) | 314 (40.9) | 0.001 |
Yes | 1982 (53.9) | 1528 (52.5) | 454 (59.1) | ||
FS: ADL | Independent (6) | 1623 (44.1) | 1368 (47.0) | 255 (33.2) | < 0.0001 |
Dependent (> 6) | 2058 (55.9) | 1544 (53.0) | 514 (66.8) | ||
FS: IADLa | Independent (5(male)/8(female)) | 1267 (34.5) | 1072 (36.9) | 195 (25.5) | < 0.0001 |
Dependent (< 5(male)/8(female) | 2401 (65.5) | 1831 (63.1) | 570 (74.5) | ||
Falls history in the past 12 months | No falls | 2400 (65.2) | 2039 (70.0) | 361 (46.9) | < 0.0001 |
Falls | 1281 (34.8) | 873 (30.0) | 408 (53.1) | ||
Fear of fallinga | Never | 2027 (55.3) | 1664 (57.4) | 363 (47.3) | < 0.0001 |
Sometimes / often / always | 1637 (44.7) | 1233 (42.6) | 404 (52.7) | ||
VAS for fatiguea | No fatigue (0) | 937 (26.3) | 756 (26.7) | 181 (24.4) | 0.193 |
Presence of fatigue (≥1) | 2632 (73.7) | 2071 (73.3) | 561 (75.6) | ||
VAS for paina | No pain (0) | 1810 (50.1) | 1453 (50.8) | 357 (47.4) | 0.099 |
Presence of pain (≥1) | 1804 (49.9) | 1408 (49.2) | 396 (52.6) | ||
MMSEa | Normal cognition (≥24) | 2686 (80.2) | 2184 (82.1) | 502 (72.5) | < 0.0001 |
Cognitive impairment (< 24) | 665 (19.8) | 475 (17.9) | 190 (27.5) | ||
GDSa | Not at risk for depression (< 5) | 2297 (66.8) | 1859 (68.2) | 438 (61.4) | 0.001 |
At risk for depression (≥5) | 1140 (33.2) | 865 (31.8) | 275 (38.6) | ||
MNA-SFa | Normal nutritional status (≥12) | 760 (20.7) | 624 (21.5) | 136 (17.8) | 0.023 |
Risk of malnutrition/ malnourished (< 12) | 2913 (79.3) | 2284 (78.5) | 629 (82.2) |